Current Value
$15.381 Year Return
Current Value
$15.381 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HNRG | -17.90% | $681.17M | +102.69% | 0.00% |
VSA | -13.74% | $8.67M | -19.04% | 0.00% |
MVO | -13.33% | $66.47M | -37.17% | 21.45% |
GRPN | -12.71% | $1.40B | +130.05% | 0.00% |
CEG | -12.67% | $96.10B | +45.97% | 0.48% |
HUSA | -12.55% | $19.66M | -19.53% | 0.00% |
CMP | -12.23% | $916.48M | +110.72% | 0.00% |
DFDV | -12.15% | $300.56M | +2,130.16% | 0.00% |
JBI | -11.50% | $1.26B | -28.39% | 0.00% |
LVO | -11.39% | $86.96M | -38.44% | 0.00% |
RDNT | -11.34% | $4.18B | -6.09% | 0.00% |
QLYS | -10.74% | $5.23B | +0.41% | 0.00% |
HY | -10.66% | $748.58M | -37.56% | 3.29% |
PRM | -10.40% | $2.26B | +92.08% | 0.00% |
CLS | -10.29% | $17.81B | +164.65% | 0.00% |
TGI | -10.26% | $2.00B | +63.68% | 0.00% |
GLDD | -9.78% | $812.40M | +39.39% | 0.00% |
STRL | -9.42% | $6.96B | +96.28% | 0.00% |
ZVIA | -9.37% | $204.80M | +359.60% | 0.00% |
AGX | -9.13% | $2.81B | +186.20% | 0.69% |
Yahoo
TEM's Q1 revenues jump 75.4%, powered by soaring genomics sales, strategic deals and new test launches.
Yahoo
Gammagard liquid ERC is approved under the brand name Deqsiga by the European Medicines Agency.
Yahoo
OSAKA, Japan & CAMBRIDGE, Mass., June 30, 2025--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin (IG) therapy with low immunoglobulin A (IgA) content, as replacement therapy for people two years of age and older with primary immunodeficiency (PI). As a ready-to-use liquid, GAMMAGARD LI
Yahoo
TEM is scaling fast; Data and Services revenues soar 43%, fueled by big-name pharma and AI model deals.
Yahoo
ADMA rides on record Asceniv sales and FDA-backed yield boost, but valuation concerns and EPS downgrades cloud its outlook.
SeekingAlpha
Denali Therapeutics: Navigating Through Recent Setbacks
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVS | 47.94% | $234.94B | +15.95% | 3.27% |
GSK | 47.86% | $77.95B | +0.13% | 4.18% |
AZN | 47.63% | $220.60B | -7.38% | 2.19% |
HLN | 45.04% | $46.13B | +21.28% | 1.73% |
CCEP | 43.13% | $43.12B | +27.16% | 2.32% |
VICI | 43.08% | $35.20B | +20.04% | 5.18% |
CB | 42.96% | $112.24B | +10.23% | 1.30% |
NGG | 42.42% | $69.22B | +19.52% | 4.29% |
KHC | 42.11% | $32.03B | -15.67% | 5.93% |
MDLZ | 41.42% | $90.07B | +4.85% | 2.72% |
ING | 41.07% | $68.20B | +27.18% | 5.29% |
WTRG | 41.02% | $10.40B | +1.01% | 3.50% |
GMRE | 41.00% | $478.18M | -20.11% | 10.93% |
WPC | 40.91% | $13.87B | +15.36% | 5.60% |
CUBE | 40.70% | $9.81B | -2.78% | 4.79% |
MFA | 40.49% | $996.76M | -7.87% | 14.52% |
VOD | 40.31% | $26.11B | +20.70% | 4.54% |
UL | 40.26% | $150.63B | +11.64% | 3.17% |
BUD | 40.16% | $121.58B | +15.45% | 1.63% |
GLPI | 39.92% | $13.25B | +9.34% | 6.32% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EFAV | 65.40% | $5.50B | 0.2% |
DWX | 58.71% | $478.17M | 0.45% |
SCHY | 57.91% | $1.18B | 0.08% |
IDLV | 56.54% | $400.39M | 0.25% |
HDEF | 56.15% | $2.03B | 0.09% |
QEFA | 54.99% | $887.38M | 0.3% |
RODM | 54.65% | $1.15B | 0.29% |
IGRO | 54.18% | $1.20B | 0.15% |
JPIN | 54.08% | $345.71M | 0.37% |
EFV | 54.01% | $26.01B | 0.33% |
RWX | 53.65% | $407.20M | 0.59% |
DTH | 53.43% | $439.15M | 0.58% |
KXI | 52.82% | $856.60M | 0.41% |
DWM | 52.55% | $567.99M | 0.48% |
VYMI | 52.41% | $10.92B | 0.17% |
ACWV | 52.40% | $3.34B | 0.2% |
GCOW | 52.38% | $2.32B | 0.6% |
PPH | 52.21% | $610.46M | 0.36% |
EWU | 52.20% | $3.05B | 0.5% |
EWL | 52.15% | $1.33B | 0.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CORN | 0.04% | $44.67M | 0.2% |
IBDQ | 0.08% | $2.98B | 0.1% |
ETHW | -0.39% | $267.74M | 0% |
QETH | -0.53% | $22.92M | 0.25% |
CETH | -0.57% | $22.90M | 0% |
EZET | -0.62% | $35.19M | 0% |
ETHV | -0.67% | $119.24M | 0% |
CLSE | 0.70% | $190.30M | 1.44% |
ETHA | -0.73% | $4.43B | 0.25% |
ETH | -0.75% | $1.29B | 0% |
ETHE | 0.79% | $2.84B | 2.5% |
FETH | -0.80% | $1.25B | 0.25% |
BOXX | -0.91% | $6.80B | 0.19% |
TBLL | 1.08% | $2.13B | 0.08% |
OILK | -1.20% | $71.87M | 0.69% |
TPMN | 1.22% | $30.70M | 0.65% |
USO | -1.31% | $1.13B | 0.6% |
DBO | 1.37% | $228.24M | 0.77% |
USL | -1.47% | $42.23M | 0.85% |
UGA | -1.59% | $72.33M | 0.97% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -34.24% | $162.43M | 0.5% |
UUP | -33.56% | $201.63M | 0.77% |
VIXY | -17.14% | $164.54M | 0.85% |
TAIL | -10.25% | $99.63M | 0.59% |
KCCA | -9.85% | $109.43M | 0.87% |
UNG | -8.96% | $360.54M | 1.06% |
CTA | -8.89% | $1.06B | 0.76% |
CLIP | -7.41% | $1.51B | 0.07% |
SGOV | -6.43% | $49.21B | 0.09% |
DEFI | -5.83% | $14.63M | 0.94% |
KRBN | -5.38% | $160.17M | 0.85% |
YBTC | -5.27% | $226.39M | 0.96% |
BITO | -5.21% | $2.65B | 0.95% |
BITB | -5.06% | $4.25B | 0.2% |
EZBC | -5.04% | $553.90M | 0.29% |
GBTC | -5.02% | $19.95B | 1.5% |
BTCO | -5.02% | $558.98M | 0.39% |
FBTC | -5.01% | $21.65B | 0.25% |
HODL | -4.97% | $1.68B | 0.25% |
BRRR | -4.94% | $629.05M | 0.25% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DDOG | 0.01% | $46.63B | +2.67% | 0.00% |
AZTA | 0.02% | $1.50B | -36.77% | 0.00% |
KE | 0.03% | $489.07M | -7.30% | 0.00% |
SG | -0.04% | $1.69B | -49.28% | 0.00% |
WBA | -0.08% | $9.95B | +3.51% | 4.36% |
ALGT | -0.08% | $1.08B | +18.85% | 0.00% |
CIVI | 0.08% | $2.74B | -57.04% | 6.71% |
CBRL | -0.09% | $1.51B | +72.24% | 1.48% |
TZOO | -0.10% | $146.68M | +75.10% | 0.00% |
LOCO | 0.10% | $344.40M | +4.66% | 0.00% |
REPX | 0.11% | $599.03M | -5.16% | 5.48% |
DLNG | 0.12% | $131.88M | -7.91% | 4.05% |
LFVN | -0.12% | $168.68M | +123.71% | 1.22% |
NEO | -0.12% | $952.34M | -46.10% | 0.00% |
CVNA | 0.12% | $46.37B | +168.61% | 0.00% |
TARS | -0.14% | $1.70B | +39.82% | 0.00% |
TMCI | 0.18% | $383.09M | -7.87% | 0.00% |
FVRR | -0.19% | $1.04B | +26.47% | 0.00% |
GORV | -0.20% | $27.07M | -91.17% | 0.00% |
GLNG | 0.21% | $4.28B | +29.85% | 2.44% |